Cite
HARVARD Citation
Pokuri, V. et al. (2018). Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC). American journal of clinical oncology. p. . [Online].